UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
27th April 2026 Uncategorised 0
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants

More: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
Source: News
